OPANA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals, Inc.. The primary component is Oxymorphone Hydrochloride.
| Product ID | 63481-613_14241cb2-6da3-45fe-8c75-f53717b57e13 |
| NDC | 63481-613 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OPANA |
| Generic Name | Oxymorphone Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-06-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021611 |
| Labeler Name | Endo Pharmaceuticals, Inc. |
| Substance Name | OXYMORPHONE HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2006-06-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-06-26 |
| Marketing End Date | 2010-04-20 |
| Marketing Category | NDA |
| Application Number | NDA021611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-06-26 |
| Marketing End Date | 2020-04-30 |
| Ingredient | Strength |
|---|---|
| OXYMORPHONE HYDROCHLORIDE | 10 mg/1 |
| SPL SET ID: | 10d4a5d9-9cb8-4dcf-9836-34c377990128 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63481-612 | OPANA | OPANA |
| 63481-613 | OPANA | OPANA |
| 0054-0283 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
| 0054-0284 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
| 0115-1231 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1232 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1233 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1234 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1315 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1316 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
| 0115-1317 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OPANA 77471861 3553676 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2008-05-12 |
![]() OPANA 77471835 3585918 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2008-05-12 |
![]() OPANA 76665614 3252736 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2006-09-05 |
![]() OPANA 76478457 3060635 Live/Registered |
Endo Pharmaceuticals Inc. 2002-12-20 |